Yongzheng Li

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2019, bioRxiv.

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2019, bioRxiv.

A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing

Yiliang Zhang, Yan Wang, Lei Yin, 2020, Genome Biology.

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy

Dehe Wang, Yu Zhou, Peng Bai, 2021, Frontiers in Immunology.

Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.

Lei Yin, Zaiqiao Sun, Jin Zhou, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing

Yiliang Zhang, Yan Wang, Lei Yin, 2020, Genome Biology.

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2021, Oncoimmunology.

Characters of neoantigens in cancer immunotherapy

P. Marrack, J. Kappler, Peng Bai, 2020 .

Characters of neoantigens in cancer immunotherapy 1

P. Marrack, J. Kappler, Peng Bai, 2019 .